top of page

NCI-2019-08392

A PHASE 1 STUDY OF ZN-c3 AS A SINGLE AGENT IN SUBJECTS WITH SOLID TUMORS


This study is testing a new medicine called ZN-c3 to see if it's safe for people with solid tumors. They want to see how well the medicine works on its own and if it can help treat cancer.


For more information about the trial, click the link below:

Clinical Trial Site: Sinai


To see all available clinical trials click here.



Recent Posts

See All

NCI-2023-00614

A Phase 3 Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Versus Investigator's Choice of...

NCI-2021-00222

NRG-BR007: A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone...

NCT01042379

I-SPY TRIAL: Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2. This research...

Comments

bottom of page